July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Elovanoid profiling of iPSC-RPE derived from a family affected by Late-Onset Retinal Degeneration reveals attenuated neuroprotective signaling in patients
Author Affiliations & Notes
  • Bokkyoo Jun
    Neuroscience Center, LSU Health Sciences Center, New Orleans, Louisiana, United States
  • Kiyoharu Joshua Miyagishima
    NEI, Laurel, Maryland, United States
  • Ruchi Sharma
    NEI, Laurel, Maryland, United States
  • Catherine A Cukras
    NEI, Laurel, Maryland, United States
  • Paul Sieving
    NEI, Laurel, Maryland, United States
  • Sheldon S Miller
    NEI, Laurel, Maryland, United States
  • Kapil Bharti
    NEI, Laurel, Maryland, United States
  • Nicolas G Bazan
    Neuroscience Center, LSU Health Sciences Center, New Orleans, Louisiana, United States
  • Footnotes
    Commercial Relationships   Bokkyoo Jun, None; Kiyoharu Miyagishima, None; Ruchi Sharma, None; Catherine Cukras, None; Paul Sieving, None; Sheldon Miller, None; Kapil Bharti, None; Nicolas Bazan, Elovanoid PCT# PCT/US16/21429 (P)
  • Footnotes
    Support  NEI grant EY005121 and the Eye, Ear, Nose and Throat Foundation
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3051. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bokkyoo Jun, Kiyoharu Joshua Miyagishima, Ruchi Sharma, Catherine A Cukras, Paul Sieving, Sheldon S Miller, Kapil Bharti, Nicolas G Bazan; Elovanoid profiling of iPSC-RPE derived from a family affected by Late-Onset Retinal Degeneration reveals attenuated neuroprotective signaling in patients. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3051.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine how the biosynthetic pathway of elovanoid synthesis is altered by the mutation (S163R) in CTRP5 found in Late-Onset Retinal Degeneration.

Methods : We generated induced pluripotent stem cells (iPSCs) from L-ORD patients and unaffected siblings (controls) and differentiated them into retinal pigment epithelium (RPE). iPSC-RPE in serum free media were fed approximately 5 photoreceptors (POS)/cell for 4 hours to recapitulate shedding and disc phagocytosis or incubated with 1µM 32:6 and 34:6 free fatty acids (VLC-PUFAs) for 24 hours in 0.5% serum containing media. Media and cell lysate were collected for LC-MS/MS-based metabolipidomic analysis.

Results : Metabolipidomic analysis revealed iPSC-RPE fed POS or VLC-PUFAs secrete stable elovanoid biosynthetic intermediates (27s-hydroxy 32:6 n-3 and 29s-hydroxy 34:6 n-3) in a polarized manner, predominantly apical. Control iPSC-RPE secrete significantly more elovanoids, ELV-N32 and ELV-N34, compared to patients. In the absence of POS or VLC-PUFAs 27s-hydroxy 32:6 n-3 was still detected in controls, but not patient iPSC-RPE. There were no differences observed in the apical or basal media composition of secreted DHA, arachidonic acid (AA) , or eicosapentaenoic acid or in the amounts of mono-hydroxy DHA and AA metabolites in cell lysates in patients compared to controls. However, DHA-derived lipid mediator, neuroprotectin D1 (NPD1) was found to be secreted significantly higher in controls (p<0.05).

Conclusions : Our data suggests that CTRP5 is important for omega-3 fatty acid metabolism in POS shedding and phagocytosis in RPE and that elovanoids play a role in neuroprotection and in sustaining photoreceptor cell integrity in retinal degenerations.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×